Saturday, July 20, 2013

Healthcare most dangerous place for workplace injuries

Healthcare is the most dangerous industry for injuries and illnesses, with 653,000 nurses, aides, orderlies and others injured or falling ill every year, according to a new Public Citizen Report.
Forty-five percent of all workplace violence incidents in the USA that result in lost workdays occur in the health care sector. Among attendants, orderlies, and nursing aides in 2011, the incidence rate of injuries requiring days off work was 486 cases per 10,000 employees, over four times higher than the national average for all workers.
Even though health care workplaces are more dangerous than anywhere else, OSHA (the Occupational Safety and Health Administration) carries out relatively few inspections of health care facilities. The authors added that even when it does find safety problems, there is often not much OSHA can do because of "an absence of much needed safety standards".
Co-author, Keith Wrightson, a worker safety and health advocate for Public Citizen, said "OSHA is required by law to ensure safe conditions for every employee in the United States. The record is clear that the government has broken its promise to health care workers."
More musculoskeletal injuries are suffered by orderlies, attendants, nurses and nursing aides than workers in any other industry. Back injuries in the health care industry are estimated to cost over $7 billion every year.
Dr. L. Toni Lewis, chair of the health care division of the Service Employees International Union, which advised Public Citizen on the report, said:
In 2010, there were 152,000 workplace injuries and illnesses in the manufacturing sector, compared to a whopping 653,000 in health care.
The industry with the most inspections, construction, has been criticized for not having enough OSHA inspections and enforcements.

Wednesday, July 10, 2013

Stem-Cell Therapy Wipes out HIV in Two Patients

LONDON (Reuters) Jul 03 - Two men with HIV have been off AIDS drugs for several months after receiving stem-cell transplants for cancer that appear to have cleared the virus from their bodies, researchers reported on Wednesday.
Both patients, who were treated in Boston and had been on long-term drug therapy to control their HIV, received stem-cell transplants after developing lymphoma, a type of blood cancer.
Since the transplants, doctors have been unable to find any evidence of HIV infection, Timothy Henrich of Harvard Medical School and Brigham and Women's Hospital in Boston told an International AIDS Society conference in Kuala Lumpur.
While it is too early to say for sure that the virus has disappeared from their bodies altogether, one patient has now been off antiretroviral drug treatment for 15 weeks and the other for seven weeks.
Last July Dr. Henrich first reported that the two men had undetectable levels of HIV in their blood after their stem-cell treatment, but at that time they were still taking medicines to suppress HIV.
Using stem-cell therapy is not seen as a viable option for widespread use, since it is extremely expensive, but the latest cases could open new avenues for fighting the disease, which infects about 34 million people worldwide.
The latest cases resemble that of Timothy Ray Brown, known as "the Berlin patient," who became the first person to be cured of HIV after receiving a bone marrow transplant for leukemia in 2007. There are, however, important differences.
While Brown's doctor used stem cells from a donor with a rare genetic mutation, known as CCR5 delta 32, which renders people virtually resistant to HIV, the two Boston patients received cells without this mutation.
"Dr. Henrich is charting new territory in HIV eradication research," Kevin Robert Frost, chief executive officer of the Foundation for AIDS Research, which funded the study, said in a statement.
The latest antiretroviral AIDS drugs can control HIV for decades. But many people still do not get therapy early enough, prompting the World Health Organization to call for faster roll-out of medicines after patients test positive.
Reuters Health Information

Wednesday, July 3, 2013

MISOPRISTOL IN OBSTETRICS



In settings with limited access to health care, misoprostol is an important intervention that could reduce maternal deaths both directly and through the more cost-effective use of health services. Misoprostol is, however, a powerful drug that needs to be used with care. Evidence-based information about the safest regimens should be widely disseminated so as to prevent its inappropriate use.View at http://www.slideshare.net/drsujnanendra/misoprostol-in-obstetrics